# Savers Value Village, Inc.: overview

SVV · NYSE · CIK 1883313 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Jan 3

Pages: [Overview](/companies/svv.md) · [Financials](/companies/svv/financials.md) · [Filings](/companies/svv/filings.md) · [Insiders](/companies/svv/insiders.md)

Latest reported revenue: [$448.2m](/filings/0001883313-26-000060.md) for Q2 FY2026, three months to 2026-07-04, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001883313-26-000060).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [395](/filings/0001883313-25-000101.md) | [402 d](/filings/0001883313-26-000014.md) | [370](/filings/0001883313-26-000043.md) | [417](/filings/0001883313-26-000060.md) | [427](/filings/0001883313-25-000101.md) | [465 d](/filings/0001883313-26-000014.md) | [403](/filings/0001883313-26-000043.md) | [448](/filings/0001883313-26-000060.md) |
| Gross margin | % | [25.6%](/filings/0001883313-24-000044.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [12.3%](/filings/0001883313-25-000101.md) | [8.2% d](/filings/0001883313-26-000014.md) | [2.8%](/filings/0001883313-26-000043.md) | [8.2%](/filings/0001883313-26-000060.md) | [8.5%](/filings/0001883313-25-000101.md) | [9.3% d](/filings/0001883313-26-000014.md) | [3.1%](/filings/0001883313-26-000043.md) | [9.4%](/filings/0001883313-26-000060.md) |
| Net margin | % | [5.5%](/filings/0001883313-25-000101.md) | [(0.5%) d](/filings/0001883313-26-000014.md) | [(1.3%)](/filings/0001883313-26-000043.md) | [4.5%](/filings/0001883313-26-000060.md) | [(3.3%)](/filings/0001883313-25-000101.md) | [4.8% d](/filings/0001883313-26-000014.md) | [(1.3%)](/filings/0001883313-26-000043.md) | [4.8%](/filings/0001883313-26-000060.md) |
| Diluted EPS | $ per share | [0.13](/filings/0001883313-25-000101.md) | not reported | [(0.03)](/filings/0001883313-26-000043.md) | [0.12](/filings/0001883313-26-000060.md) | [(0.09)](/filings/0001883313-25-000101.md) | not reported | [(0.03)](/filings/0001883313-26-000043.md) | [0.14](/filings/0001883313-26-000060.md) |
| Free cash flow | $m | [(3.0) d](/filings/0001883313-25-000101.md) | [30.1 d](/filings/0001883313-26-000014.md) | [(20.2)](/filings/0001883313-26-000043.md) | [21.9 d](/filings/0001883313-26-000060.md) | [(6.3) d](/filings/0001883313-25-000101.md) | [53.2 d](/filings/0001883313-26-000014.md) | [(9.9)](/filings/0001883313-26-000043.md) | [44.8 d](/filings/0001883313-26-000060.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2022-01-01) | FY (2022-12-31) | FY2023 (2023-12-30) | FY2024 (2024-12-28) | FY2025 (2026-01-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,204](/filings/0001883313-24-000013.md) | [1,437](/filings/0001883313-25-000013.md) | [1,500](/filings/0001883313-26-000014.md) | [1,538](/filings/0001883313-26-000014.md) | [1,679](/filings/0001883313-26-000014.md) |
| Gross margin | % | [27.5%](/filings/0001883313-24-000013.md) | [27.1%](/filings/0001883313-24-000013.md) | [28.5%](/filings/0001883313-24-000013.md) | not reported | not reported |
| Operating margin | % | [15.1%](/filings/0001883313-24-000013.md) | [14.3%](/filings/0001883313-25-000013.md) | [9.5%](/filings/0001883313-26-000014.md) | [8.5%](/filings/0001883313-26-000014.md) | [7.4%](/filings/0001883313-26-000014.md) |
| Net margin | % | [6.9%](/filings/0001883313-24-000013.md) | [5.9%](/filings/0001883313-25-000013.md) | [3.5%](/filings/0001883313-26-000014.md) | [1.9%](/filings/0001883313-26-000014.md) | [1.3%](/filings/0001883313-26-000014.md) |
| Diluted EPS | $ per share | [0.57](/filings/0001883313-24-000013.md) | [0.58](/filings/0001883313-25-000013.md) | [0.34](/filings/0001883313-26-000014.md) | [0.17](/filings/0001883313-26-000014.md) | [0.14](/filings/0001883313-26-000014.md) |
| Free cash flow | $m | [135](/filings/0001883313-24-000013.md) | [59.3](/filings/0001883313-25-000013.md) | [83.4](/filings/0001883313-26-000014.md) | [28.4](/filings/0001883313-26-000014.md) | [48.6](/filings/0001883313-26-000014.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/svv/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [ARES MANAGEMENT LLC](/funds/1259313.md) | 2026-06-30 | $1.19bn | 117,449,188 |  | Unchanged |
| [BAILLIE GIFFORD & CO](/funds/1088875.md) | 2026-06-30 | $86.9m | 8,610,914 |  | Reduced −50,803 |
| [Capital Research Global Investors](/funds/1422848.md) | 2026-06-30 | $35.5m | 3,518,095 |  | Added +1,747,269 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $28.5m | 2,821,614 |  | Added +58,051 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $22.8m | 2,260,506 |  | Added +395,958 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $18.7m | 1,848,535 |  | Added +11,332 |
| [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $17.1m | 1,698,192 |  | Reduced −47,348 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $17.0m | 1,680,026 |  | Reduced −6,251 |
| [Archon Capital Management LLC](/funds/1398825.md) | 2026-06-30 | $15.3m | 1,511,470 |  | Added +214,287 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $11.7m | 1,155,812 |  | Reduced −13,236 |

## Recent filings

[All 340 filings](/companies/svv/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-13 | 20:42 ET | [8-K](/filings/0001193125-26-349410.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-349410 |
| 2026-08-11 | 20:49 ET | [8-K](/filings/0001193125-26-344910.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-344910 |
| 2026-08-06 | 21:30 ET | [10-Q](/filings/0001883313-26-000060.md) | Quarterly report, period 2026-07-04 | 0001883313-26-000060 |
| 2026-08-06 | 20:08 ET | [8-K](/filings/0001883313-26-000059.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001883313-26-000059 |
| 2026-06-11 | 20:03 ET | [8-K](/filings/0001883313-26-000051.md) | 5.07 Shareholder vote results | 0001883313-26-000051 |
| 2026-06-02 | 20:02 ET | [8-K](/filings/0001883313-26-000046.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001883313-26-000046 |
| 2026-05-06 | 21:25 ET | [10-Q](/filings/0001883313-26-000043.md) | Quarterly report, period 2026-04-04 | 0001883313-26-000043 |
| 2026-05-06 | 20:06 ET | [8-K](/filings/0001883313-26-000042.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001883313-26-000042 |
| 2026-04-27 | 20:06 ET | [DEF 14A](/filings/0001883313-26-000034.md) | Proxy statement, period 2026-06-10 | 0001883313-26-000034 |
| 2026-02-20 | 11:34 ET | [10-K](/filings/0001883313-26-000014.md) | Annual report, period 2026-01-03 | 0001883313-26-000014 |

## Latest annual report

[Form 10-K for the fiscal year ended Jan 3, 2026](/filings/0001883313-26-000014.md), filed Feb 20, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1883313
- Tickers: SVV
- Exchange: NYSE
- SIC code: 5900 Retail-Miscellaneous Retail
- State of incorporation: WA
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.